Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 2902
Selected: 0
NCT IDTitle
NCT00886795Safety and Efficacy of Abatacept in Subjects With Chronic Urticaria Who Have Had an Inadequate Response to Anti-histamine Therapy
NCT04594811NT-I7 in Combination With Nivolumab in Advanced Gastric, Gastro-Esophageal Junction or Esophageal Adenocarcinoma
NCT04328298French Register Of Patients With Hemopathy Eligible For CAR-T Cell Treatment (DESCAR-T)
NCT01585987An Efficacy Study in Gastric and Gastroesophageal Junction Cancer Comparing Ipilimumab Versus Standard of Care Immediately Following First Line Chemotherapy
NCT01642004Study of BMS-936558 (Nivolumab) Compared to Docetaxel in Previously Treated Advanced or Metastatic Squamous Cell Non-small Cell Lung Cancer (NSCLC) (CheckMate 017)
NCT02857426A Study of Nivolumab in Relapsed/Refractory Primary Central Nervous System Lymphoma (PCNSL) and Relapsed/Refractory Primary Testicular Lymphoma (PTL)
NCT00726726Drug Interaction Study With a Potential Alzheimer's Disease Compound
NCT00165334Cetuximab and Vinorelbine in Elderly Subjects With Lung Cancer
NCT03083821A Study to Provide a Better Understanding of Baraclude's Pharmacokinetic Properties in a Real World Clinical Setting
NCT00035633A Phase III Study of Entecavir vs Lamivudine in Adults With Chronic Hepatitis B Infection and Positive for Hepatitis B E Antigen
NCT05399732Efficacy and Safety in Transfusion Independent Non-severe Aplastic Anemia
NCT06568458A Study to Assess the Extent of Drug Interaction Between BMS-986278 and Nintedanib, the Relative Bioavailability of BMS-986278 in Tablet and the Effect That Food Has on BMS-986278 in Tablet Formulations in Healthy Participants
NCT01888900New Treatment Response in People With and Without Cirrhosis From Chronic Hepatitis C
NCT02186249Expanded Access Program With Nivolumab in Combination With Ipilimumab in Patients With Tumors Unable to be Removed by Surgery or Metastatic Melanoma
NCT02142218Expanded Access Program With Nivolumab to Treat Melanoma
NCT03834623Avadomide (CC-122) in Combination With Nivolumab in Advanced Melanoma
NCT00362037I SELECT - Irbesartan In Hypertensive Patients With Left Ventricular Hypertrophy
NCT07423546A PET/MRI Study of Cobenfy on Dopamine Transmission in Schizophrenia
NCT02323594A Bioequivalence Study of Daclatasvir Tablets and Bioavailability Studies of Daclatasvir and Asunaprevir
NCT03000673A Study to Evaluate Safety of Single Doses of BMS-986177 in Patients With End Stage Renal Disease (ESRD) Treated With Hemodialysis
NCT00460954A Multiple-Dose Study of Sinemet® CR (Carbidopa/Levodopa) in Healthy Subjects
NCT02175966Short Duration Combination Therapy With Daclatasvir, Asunaprevir, BMS-791325 and Sofosbuvir in Subjects Infected With Chronic Hepatitis-C (FOURward Study)
NCT07608731Golcadomide With Pemetrexed, Rituximab, and Dexamethasone for Relapsed and Refractory CNS Lymphomas
NCT03532451Phase Ib Feasibility Trial of Neoadjuvant Nivolumab/Lirilumab in Cisplatin-Ineligible Muscle-Invasive Bladder Cancer
NCT00162188An Expanded Access Study of Oral Liquid Efavirenz in the Treatment of Children With HIV Infection: Canada
NCT00874770Safety and Efficacy of Daclatasvir (BMS-790052) Plus Standard of Care (Pegylated-interferon Alpha and Ribavirin)
NCT01741545Safety and Efficacy Study in Subjects With Chronic HCV and Underlying Hemophilia
NCT01818856Pharmacokinetic Interactions Between Telaprevir and Un-boosted Atazanavir
NCT05162222A Study to Evaluate the Effect of Co-administration of Itraconazole or Diltiazem on the Single-dose of Danicamtiv in Healthy Participants
NCT02369653A Study of the Safety and Effectiveness of Apixaban in Preventing Blood Clots in Children With Leukemia Who Have a Central Venous Catheter and Are Treated With Asparaginase
NCT04106414Study of BMS-986205 and Nivolumab in Endometrial Cancer or Endometrial Carcinosarcoma That Has Not Responded to Treatment
NCT00002349A Pilot Study to Compare the Antiviral and Immunologic Effects of Stavudine ( d4T ) Versus Placebo in Subjects With Evidence of Recent HIV Infection.
NCT0066645818-week add-on to Metformin Comparison of Saxagliptin and Sitagliptin in Adult Patients With Type 2 Diabetes (T2D)
NCT01583244Korean Post-marketing Surveillance for Orencia®
NCT06481306A Study to Evaluate BMS-986470 in Healthy Volunteers and Participants With Sickle Cell Disease
NCT04577638Accelerated Radio-Immunotherapy for Lung Cancer
NCT04667663CPD-DARA in Patients With Relapsed/Refractory Multiple Myeloma.
NCT02098616Rapid Hepatitis C Elimination Trial- A Pilot Study of Daclatasvir/Asunaprevir/BMS-791325 With or Without Ribavirin To Treat Hepatitis C Virus
NCT03285321Unresectable Stage IIIA/IIIB Non-small Cell Lung Cancer (NSCLC)
NCT06045806A Study to Compare the Efficacy and Safety of Idecabtagene Vicleucel With Lenalidomide Maintenance Therapy Versus Lenalidomide Maintenance Therapy Alone in Adult Participants With Newly Diagnosed Multiple Myeloma Who Have Suboptimal Response After Autologous Stem Cell Transplantation
NCT00119678Abatacept in the Treatment and Prevention of Active Systemic Lupus Erythematosus (SLE) Flares in Combination With Prednisone
NCT00608543Aripiprazole Augmentation of SSRI Therapy in Treatment Refractory Depression
NCT03329885A Study of Experimental Medication BMS-986251, Taken by Mouth, in Healthy Participants and Patients With Average to Very Serious Psoriasis
NCT00135408A Study of MDX-010 (BMS-734016) Administered With or Without Prophylactic Oral Budesonide
NCT05303220A Study to Assess Relative Bioavailability of Branebrutinib, From a Tablet Formulation to the Capsule Formulation, the Effect of Food on the Bioavailability of Branebrutinib From a Tablet Formulation, and the Safety and Drug Levels of Branebrutinib From a Tablet Formulation in Healthy Participants
NCT03061188Phase I/Ib Study of Nivolumab & Veliparib in Patients With Advanced Solid Tumors & Lymphoma
NCT06045689A Study to Assess Luspatercept in Lower-risk Myelodysplastic Syndrome Participants
NCT05621096Low Dose Radiation as Bridging Therapy in Relapsed B-Cell Non-Hodgkin Lymphoma
NCT02932969Study With Healthy Japanese and Non-Asian Participants With BMS-986231
NCT00481325Study of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder